NCT01198418

Brief Summary

This is a CCTG sponsored trial in collaboration with UCSD-AVRC investigators to get more information about the methods that are used on the internet to provide information on how to reduce the risk of giving or getting infections that are often or usually passed from one person to another during sexual or intimate contact (sexually transmitted infection (STI)). STIs include chlamydia, gonorrhea and syphilis. The purpose of this study is to develop methods that will allow someone who is living with HIV an easy way that they can get information and learn of ways on their own that can decrease their chances of getting sexually transmitted infections and ways that they can reduce the chance that they may transmit HIV to others.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
181

participants targeted

Target at P75+ for not_applicable

Timeline
Completed

Started Jul 2010

Longer than P75 for not_applicable

Geographic Reach
1 country

3 active sites

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

July 9, 2010

Completed
2 months until next milestone

First Submitted

Initial submission to the registry

September 8, 2010

Completed
2 days until next milestone

First Posted

Study publicly available on registry

September 10, 2010

Completed
7.1 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

October 18, 2017

Completed
22 days until next milestone

Study Completion

Last participant's last visit for all outcomes

November 9, 2017

Completed
Last Updated

May 12, 2020

Status Verified

May 1, 2020

Enrollment Period

7.3 years

First QC Date

September 8, 2010

Last Update Submit

May 8, 2020

Conditions

Keywords

STIMSMHIVPreventionMen having sex with men

Outcome Measures

Primary Outcomes (1)

  • STI incidence

    * To compare the composite STI incidence of syphilis or Chlamydia trachomatis (CT) or Neisseria gonorrhea (GC) at any mucosal site among sexually active HIV-infected men during 12 months participation in an Internet risk reduction intervention compared to those that receive a survey instrument alone. * To compare the incidence of nonspecific urethritis by urinalysis and testing for Mycoplasma genitalum and trichomonas sp. among sexually active HIV-infected men during 12 months participation in an Internet risk reduction intervention compared to those that receive a survey instrument alone.

    Baseline and follow-up visits every 3 months

Secondary Outcomes (1)

  • Evaluate risk factors of STIs

    Baseline, follow-up visits every 3 months

Study Arms (2)

Internet-based counseling

EXPERIMENTAL

Completes surveys monthly about their sexual and drug use behaviors as well as receives information designed to help reduce the chances of getting an STI.

Behavioral: Experimental

Survey Alone

NO INTERVENTION

Completes surveys monthly about their sexual and drug use behaviors

Interventions

ExperimentalBEHAVIORAL

Internet-based intervention that assesses transmission risk and provides prevention messages

Internet-based counseling

Eligibility Criteria

Age18 Years+
Sexmale
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • HIV-1 infection, as documented by any licensed screening antibody test, such as ELISA, and confirmed by a second antibody test, such as Western blot, or detectable plasma HIV-1 RNA at any time prior to study entry. If an ELISA or Western Blot are not available, HIV infection may be documented by two HIV RNA values \> 2000 copies/mL, drawn at least 24 hours apart. The HIV RNA assays should have been run at a CLIA approved laboratory or equivalent.
  • years of age or older.
  • Male.
  • At least one of the following:
  • An HIV negative or unknown status sexual partner in the past three months.
  • A sexually transmitted disease in the past 1 year (other than HIV).
  • More than 2 male partners in past year.
  • Unprotected anal sex in past 3 month.
  • Capable of signing written informed consent.
  • Read and comprehend English
  • Adequate computer skills for study.

You may not qualify if:

  • Uncontrolled psychiatric condition.
  • Drug or alcohol users with use that in the opinion of the investigator, would limit follow-up and adequate consent

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (3)

University of Southern California

Los Angeles, California, 90033, United States

Location

University of California, San Diego

San Diego, California, 92103, United States

Location

University of California, Los Angeles (Harbor)

Torrance, California, 90502, United States

Location

Related Links

MeSH Terms

Conditions

Sexually Transmitted DiseasesHIV Infections

Condition Hierarchy (Ancestors)

Communicable DiseasesInfectionsGenital DiseasesUrogenital DiseasesDisease AttributesPathologic ProcessesPathological Conditions, Signs and SymptomsBlood-Borne InfectionsSexually Transmitted Diseases, ViralLentivirus InfectionsRetroviridae InfectionsRNA Virus InfectionsVirus DiseasesImmunologic Deficiency SyndromesImmune System Diseases

Study Officials

  • Sheldon Morris, MD, MPh

    UC San Diego AntiViral Research Center (AVRC)

    PRINCIPAL INVESTIGATOR
  • Joel Milam, PhD

    University of California, San Diego

    STUDY CHAIR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
PREVENTION
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Clinical Professor

Study Record Dates

First Submitted

September 8, 2010

First Posted

September 10, 2010

Study Start

July 9, 2010

Primary Completion

October 18, 2017

Study Completion

November 9, 2017

Last Updated

May 12, 2020

Record last verified: 2020-05

Locations